Major Vascular Injuries in Elective Thoracic Surgery: A 10-Year Single-Center Experience

NCT ID: NCT07100509

Last Updated: 2025-08-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

11 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-01

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study retrospectively examines major vascular injuries that occurred during elective thoracic surgeries over a 10-year period at a single tertiary care center. Although these injuries are rare, they can lead to life-threatening complications. The study aims to determine how often these injuries happen, what causes them, and how they are managed during surgery. It also evaluates the role of preoperative imaging and planning, including cardiovascular surgery team involvement, in preventing or managing these events. The findings are intended to help improve surgical safety and guide future preventive strategies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thoracic Surgery Vascular Injury Intraoperative Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients With Intraoperative Vascular Injury

This cohort includes patients who experienced major intraoperative vascular injuries during elective thoracic surgeries between January 2015 and December 2024. All patients underwent surgical repair of the injured vessel, such as primary suturing, graft interposition, or ligation. No randomization or intervention assignment was performed. Data were collected retrospectively from medical records to evaluate patient characteristics, surgical details, transfusion requirements, preoperative imaging findings, complication rates, and clinical outcomes. No biospecimens were collected or retained.

Major Vascular Injury During Elective Thoracic Surgery

Intervention Type OTHER

This exposure refers to patients who experienced major vascular injuries during elective thoracic surgery. Injuries involved central vessels such as the subclavian artery, brachiocephalic vein, superior vena cava, and innominate vein. No experimental intervention was applied. The study retrospectively evaluated the surgical management, transfusion requirements, preoperative planning, and clinical outcomes associated with these intraoperative events.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Major Vascular Injury During Elective Thoracic Surgery

This exposure refers to patients who experienced major vascular injuries during elective thoracic surgery. Injuries involved central vessels such as the subclavian artery, brachiocephalic vein, superior vena cava, and innominate vein. No experimental intervention was applied. The study retrospectively evaluated the surgical management, transfusion requirements, preoperative planning, and clinical outcomes associated with these intraoperative events.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who underwent elective thoracic surgery between January 2015 and December 2024
* Development of a major intraoperative vascular injury during surgery
* Injury involving central vessels such as the subclavian artery or vein, brachiocephalic vein, innominate artery or vein, superior vena cava (SVC), or thoracic aorta
* Availability of complete operative and postoperative medical records
* Underwent surgical repair of the vascular injury (e.g., grafting, primary repair, ligation)

Exclusion Criteria

* Patients undergoing emergency thoracic surgery
* Injuries limited to pulmonary artery or its branches
* Minor bleeding from peripheral vessels that did not require major intervention
* Postoperative vascular complications (e.g., delayed hemorrhage, pseudoaneurysm)
* Missing or incomplete operative records
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Caner İşevi, MD

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Caner İşevi, MD

MD

Responsibility Role SPONSOR_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B.30.2.ODM.0.20.08/ 481

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.